Skip to main content

COVID-19

January 08, 2025

Antimicrobial Stewardship: Integrating Diagnostics and Data-Driven Solutions for a Resilient Future

With the landscape of healthcare rapidly evolving, diagnostic innovation, health equity, and the strategic value of laboratory services are emerging as critical focal points.
  • November 23, 2023

    Clinical and Health Inequality Risk Factors for Non-COVID-Related Sepsis During the Global COVID-19 Pandemic

  • October 14, 2023

    The BIOFIRE® Blood Culture Identification 2 (BCID2) Panel: Rapid Diagnostics For Improved Antimicrobial Stewardship And Patient Outcomes

  • September 28, 2023

    Use Of Electronic Clinical Data To Track Incidence And Mortality For Sars-cov-2-associated Sepsis

  • September 05, 2023

    3 Reasons Why Pharmacies And Labs Should Partner To Improve Health Care

  • July 18, 2023

    A Common Allele of HLA is Associated with Asymptomatic SARS-COV-2 Infection

  • July 12, 2023

    Leveraging Artificial Intelligence in the Fight Against Infectious Diseases

  • May 06, 2023

    Early empiric antibiotic use in COVID-19 patients: results from the international VIRUS registry

    Results from the Society of Critical Care Medicine Discovery VIRUS international COVID-19 Registry aim to determine the rate and factors associated with early empiric antibiotic (EEAB) treatment to help set goals for antimicrobial stewardship efforts, in the post-pandemic era.

  • February 06, 2023

    The Increasingly Critical Role of Space Planning in Lab Operations

  • January 30, 2023

    Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis

  • January 24, 2023

    Expect Infectious Diseases to Skyrocket in the ICU

    According to predictions from professor and practicing intensivist, Dr. Hannah Wunsch, war, multidrug resistance, climate change, emerging diseases, and reduced confidence in vaccination will be among the factors that influence an expected increase in infectious diseases in the ICU.

  • December 14, 2022

    Diagnostics and Data Can Fill Gaps in Antimicrobial Stewardship Left by COVID-19

    In this article, Brian Raux, PharmD, discusses the global impact COVID-19 has had on the rise of antimicrobial resistance (AMR) and the alarming increase of hospital-acquired infections (HAI). 

  • November 20, 2022

    The Importance of Diagnostics and AMS in the Context of COVID-19

  • November 17, 2022

    Webinar: Confronting the Impact of the Pandemic on ASP and Pneumonia

  • October 13, 2022

    COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease?

  • October 04, 2022

    Neurogenesis is disrupted in human hippocampal progenitor cells upon exposure to serum samples from hospitalized COVID-19 patients with neurological symptoms

  • September 07, 2022

    CDC 2022 Special Report: COVID-19 U.S. Impact on Antimicrobial Resistance

  • August 08, 2022

    Clinical Sepsis Phenotypes in Critically Ill COVID-19 Patients

  • May 22, 2022

    Baricitinib Versus Dexamethasone for Adults Hospitalized with COVID-19

  • March 02, 2022

    APIC PODCAST: Let’s Talk About the Impact of the COVID-19 Pandemic on Healthcare-Associated Infections

  • February 20, 2022

    Infection Management Coalition (IMC) Releases First White Paper

  • February 03, 2022

    VIEWPOINTS SERIES: The Impact of COVID-19 on Maternal Care

  • February 02, 2022

    Genetic Variants in Very Sick COVID Patients May Explain Differences in Illness

  • January 23, 2022

    How RNA Reference Materials Can Help Standardize COVID-19 Tests

  • January 03, 2022

    CDC Launches Two Global Networks and Awards $22 Million to Combat Antimicrobial Resistance and Infectious Diseases

  • January 02, 2022

    The Omicron Variant is Deepening Severe Staffing Shortages in Medical Laboratories Across the US

  • November 29, 2021

    APIC PODCAST Antimicrobial Stewardship During the COVID-19 Pandemic: A Journey of Twists and Turns

  • October 05, 2021

    Microbiology Knows No Borders: What Lessons COVID-19 Can Teach Us About Antimicrobial Stewardship

  • July 11, 2021

    Coronavirus Disease 2019 As Cause Of Viral Sepsis: A Systematic Review And Meta-analysis

  • July 06, 2021

    Establishing a Distribution Network For COVID-19 Monoclonal Antibody Therapy

  • June 29, 2021

    The Double-Edged Sword of COVID-19 on the Use of Antibiotics

  • June 29, 2021

    Dealing With Potential Long-Term Effects of COVID-19 Infection

  • June 24, 2021

    IDSA Updates Guidance To Support Use of Tocilizumab for COVID-19

  • June 20, 2021

    Association of Changes in Seasonal Respiratory Virus Activity and Ambulatory Antibiotic Prescription

  • June 08, 2021

    Study of Severe COVID-19 Helps Uncover the Roots of Sepsis

  • June 01, 2021

    Reducing The Use Of Empiric Antibiotic Therapy In Covid-19 On Hospital Admission

  • May 10, 2021

    Is It COVID or the Flu? New Combo Tests Can Find Out

  • April 08, 2021

    Performance Characteristics of Serological Assays

  • March 29, 2021

    Surveillance System Tracks COVID Infection Hotspots in Hospitals

  • March 28, 2021

    How mRNA Technology Could Change the World

  • February 24, 2021

    Dual Health Threats: AMR & COVID-19

    We invite you to download and share this comprehensive infographic to educate patients about the importance of infection prevention measures and the appropriate use of antimicrobials.

  • February 21, 2021

    How a 1960s Discovery in Yellowstone Made Millions of COVID-19 PCR Tests Available

  • January 20, 2021

    CIDRAP Presents, An Imperfect Storm